查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014953

男士理容市场：2026-2032年全球市场预测（依治疗类型、技术、服务提供者类型、治疗频率和效果持续时间划分）

Male Aesthetics Market by Treatment Type, Technology, Provider Type, Treatment Frequency, Outcome Duration - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，男士护理市场价值将达到 66.1 亿美元，到 2026 年将成长至 71 亿美元，到 2032 年将达到 111.7 亿美元，复合年增长率为 7.77%。

主要市场统计数据
基准年 2025 66.1亿美元
预计年份：2026年 71亿美元
预测年份 2032 111.7亿美元
复合年增长率 (%) 7.77%

男士理容市场不断发展，在标准化、技术进步和数位化病人历程的推动下，服务提供和价值创造正在重塑。

男士美容市场已从最初以少数诊所和疗程为主的小众市场，发展成为现代个人护理和医疗服务的主流组成部分。最初，男士美容主要集中于美容领域，专注于少数几种疗程；如今，它涵盖了广泛的选择，包括微创、非侵入性、外科手术和居家护理，并与皮肤科、头髮护理和健康管理等领域相互交融。这种转变反映了人口结构的变化和文化接受度的提高，越来越多的男性开始寻求能够解决老龄化、脱髮、体型和皮肤健康等问题的服务，并且不再带有任何偏见。

微创治疗、核心能量技术和新型治疗模式的快速融合正在重塑患者的期望和竞争动态。

多重变革正在汇聚，重塑男士美容市场，对策略远见和营运灵活性提出了更高的要求。首先，随着消费者寻求更温和的替代方案，治疗类别正在加速细分。如今，治疗范围已扩展至“微创手术”、“非侵入性手术”、“外科手术”以及“外用治疗和居家护理”，其中脂肪移植、雷射辅助抽脂、抽脂和埋线拉提等特定技术与非手术毛髮再生、皮肤修復和塑形方法并存。其次，雷射、射频和超音波等核心技术的普及，使医疗服务提供者能够提供个人化、实证的治疗方案，从而减少恢復时间并扩大应用范围。

贸易政策的转变正在重塑医疗设备、耗材和诊所营运基础的整个价值链的采购、定价和业务永续营运。

预计在2025年前后公布的贸易政策趋势，将为依赖跨国供应链的製造商、经销商和诊所带来更复杂的商业环境。关税调整加剧了医疗设备和居家医疗技术中使用的资本设备、耗材和专用组件的成本压力。因此，采购团队正在重新审视筹资策略和库存政策，以减轻前置作业时间波动和利润率下降的影响。同时，一些製造商正在加快区域性生产和组装，以降低进口关税的影响，并更快地应对当地法规和报销机制的变化。

将治疗方法、底层技术、交付模式和治疗效果持续时间连结起来的多维细分框架揭示了策略性成长槓桿。

细分市场分析揭示了独特的市场需求驱动因素和营运重点，这些因素因治疗类型、技术、交付模式、治疗频率和疗效持续时间而异。依治疗类型划分，竞争格局包括微创手术以及非侵入性、外科手术和局部/居家照护等形式。微创手术类别包括脂肪移植、雷射辅助抽脂、抽脂和埋线拉提。非侵入性手术则涵盖塑形、肉毒桿菌注射、除毛、非手术生髮、色素沉淀/疤痕修復、皮肤修復和皮肤紧緻。外科手术包括身体整形、脸部整形和植髮，而局部/居家护理则包括居家护理设备和护肤。从技术角度来看，市场活动主要围绕着雷射技术、射频技术和超音波展开，每种技术都有不同的研发週期和临床证据需求。从服务提供者类型来看，该生态系统涵盖了理髮店旁的美容诊所、皮肤科诊所、连锁加盟店和医疗美容中心，每个机构都会影响转诊流量、定价权和品牌建立。根据治疗频率，患者的治疗路径从维护/加强护理和单次治疗到疗程方案不等，从而形成终身价值模型。根据效果持续时间，治疗结果​​分为“持久（24个月或以上）”、“永久性”、“半永久性（6-24个月）”或“暂时性（6个月或以下）”，这会影响预期管理和治疗后沟通。

这些细分维度之间存在可预测的交互作用。疗效持久的技术更倾向于应用于外科手术和微创领域，而非侵入性疗法和家用设备则更适合常规维护。注重便利性和治疗次数的医疗机构倾向于选择短期治疗方案和套餐计划，而专科皮肤科诊所则更注重循证的个人化治疗方案，并收取更高的费用。了解这些交集有助于精准制定产品蓝图和市场进入策略，从而更好地契合临床工作流程和病患偏好。

部署模式的区域差异和细微的监管差别，正在为美洲、欧洲、中东和非洲以及亚太市场创造独特的机会。

区域趋势造就了独特的竞争格局和需求模式，直接影响商业化策略。在美洲，男性美容医学的高消费者接受度以及医疗机构的高密度分布，为差异化的诊所模式和基于会员制的维护计划创造了机会。该地区部分地区的法规环境和支付方互动促使诊所采用灵活的定价结构和资金筹措方案，以扩大服务可近性，同时优先考虑临床疗效和病人安全。

将医疗设备创新与临床医生培训、数位化和服务型收入模式结合的公司，在客户采纳和留存方面都优于竞争对手。

目前，主要企业之间的竞争呈现出整合打入市场策略的特点，这些策略融合了产品创新、培训生态系统和服务交付能力。投资临床医生教育和认证计画的公司能够加速医疗设备的普及应用，降低治疗结果的差异性，并最终提升产品高端定位和客户復购率。同样，建立可支援多种技术和治疗适应症的模组化平台的公司能够提高客户终身价值，并降低合作诊所的客户流失率。

采取切实可行的策略措施，稳定价值链，实现治疗结果货币化，并扩大对医疗保健提供者的覆盖范围，同时保持临床可靠性和患者终身价值。

领导者应优先考虑一系列切实可行的措施，以兼顾短期韧性和中期成长。首先，透过供应商多元化、二级製造商认证以及评估区域组装方案来降低供应链风险，从而减轻关税造成的成本波动和交货延迟。其次，透过投资高品质的临床证据、真实世界结果追踪以及支持高端定位和订阅式服务的患者报告指标，将交易重点从价格转向可验证的结果。

严谨的混合方法，结合与关键相关人员的对话、整合二手证据和反覆检验，可确保获得稳健的决策见解。

本调查方法结合了与领域专家的质性与量化访谈、权威的二级资讯来源、系统的资料检验流程。主要研究包括对临床实践、医疗设备製造、分销和零售供应商等各领域代表性相关人员进行结构化访谈，以收集关于技术采纳、报销流程、患者偏好和营运挑战的第一手观点。此外，还透过对临床医生和诊所营运人员的补充问卷调查，量化了治疗频率模式、典型病人历程以及常见的采纳障碍。

为了取得可持续的成功，必须将临床证据、具有韧性的营运结构和以消费者为中心的商业化相结合，同时也要应对政策和区域方面的复杂性。

男性美容医学领域正日趋成熟，成为一个融合了临床创新、消费行为和商业性智慧的多元化市场。能够成功整合产品功能、显着疗效和可扩展的医疗服务支援系统的医疗机构和製造商将获得显着优势。治疗方法、底层技术和医疗服务提供者类型之间的相互作用，自然地创造了市场细分的机会，而这些机会可以透过个人化定价、资金筹措和病人参与策略来实现盈利。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按护理类型分類的男士美容市场

  • 微创治疗
    • 脂肪移植
    • 雷射辅助脂肪分解
    • 抽脂手术
    • 埋线拉提
  • 非侵入性治疗
    • 塑形
    • 肉毒桿菌注射
    • 除毛
    • （非手术）生髮
    • 改善色素沉淀和疤痕
    • 皮肤再生
    • 皮肤紧緻
  • 外科手术
    • 身体手术
    • 脸部手术
    • 植髮
  • 外用製剂和家庭护理
    • 家用护理设备
    • 护肤

第九章：男士美容市场：依技术划分

  • 雷射技术
  • 高频
  • 超音波

第十章：以供应商类型分類的男性美容市场

  • 美容诊所，附理髮店
  • 皮肤科诊所
  • 特许经营连锁店
  • 医疗水疗中心

第十一章：以护理频率分類的男士美容市场

  • 维护/增压
  • 单次会话
  • 系列

第十二章：依效果持续时间分類的男士美容市场

  • 持久有效（24个月或更长）
  • 永远
  • 半永久性（6-24个月）
  • 暂时（少于6个月）

第十三章：男士美容市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：男士美容市场：依群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：男士美容市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国男士美容市场

第十七章：中国男士美容市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbvie Inc.
  • Acumed, LLC by Colson Medical, LLC
  • Alma Lasers, Ltd.
  • Anthony Skin LLC
  • Candela Corporation
  • Cartessa Aesthetics
  • Cutera, Inc.
  • Cynosure, LLC
  • Galderma SA
  • Hanson Medical, Inc.
  • Implantech Associates Inc.
  • Inmode Ltd
  • Institut Straumann AG
  • Integra LifeSciences Corporation
  • Ipsen Pharma
  • Jeisys Medical Inc.
  • Johnson & Johnson Services Inc.
  • KLS Martin Group
  • Lattice Medical SAS
  • Medytox, Inc.
  • Merz Aesthetics, Inc.
  • Nobel Biocare Services AG
  • Quanta System SpA
  • Solta Medical by Bausch Health Companies Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43286DA08070

The Male Aesthetics Market was valued at USD 6.61 billion in 2025 and is projected to grow to USD 7.10 billion in 2026, with a CAGR of 7.77%, reaching USD 11.17 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.61 billion
Estimated Year [2026] USD 7.10 billion
Forecast Year [2032] USD 11.17 billion
CAGR (%) 7.77%

An evolving male aesthetics landscape driven by normalization, technological advances, and digital-first patient journeys reshaping service delivery and value creation

The male aesthetics sector has evolved from niche clinics and elective procedures into a mainstream component of contemporary personal care and medical services. What began as a primarily cosmetic conversation focused on a narrow set of interventions now includes a broad spectrum of minimally invasive, non-invasive, surgical, and at-home options that intersect with dermatology, hair care, and wellness. This shift reflects both demographic changes and cultural acceptance, where men increasingly seek services that address aging, hair loss, body composition, and skin health without stigma.

Advancements in device technologies, expanded provider footprints beyond traditional surgical settings, and growing consumer comfort with maintenance-driven regimens have collectively redefined patient journeys. In parallel, digital channels have compressed education cycles and normalized treatments through social proof and targeted content. These dynamics are reshaping clinical practice, capital allocation, training priorities, and retail positioning across the value chain. As a result, stakeholders from equipment manufacturers to clinic operators must reconcile clinical efficacy, operational scalability, and consumer convenience to remain competitive.

Looking forward, strategic differentiation will require combining clinical excellence with frictionless patient experiences, integrated digital touchpoints, and outcome-focused value propositions. Organizations that align clinical protocols with measurable aesthetic outcomes and pragmatic business models are best positioned to capture sustained demand as care pathways continue to diversify and mature.

Rapid convergence of less invasive modalities, core energy-based technologies, and new provider models rewriting patient expectations and competitive dynamics

Multiple transformative shifts are converging to reconfigure the male aesthetics market, and these changes demand both strategic foresight and operational agility. First, the fragmentation of treatment categories is accelerating as consumers seek less invasive alternatives; the treatment spectrum now spans Minimally Invasive Procedures, Non-Invasive Procedures, Surgical Procedures, and Topicals & At-Home options, while specific techniques such as Fat Transfer, Laser-Assisted Lipolysis, Liposuction, and Thread Lifts coexist alongside non-surgical Hair Restoration, Skin Resurfacing, and Body Contouring modalities. Second, the spread of core technologies including Laser Technology, Radiofrequency, and Ultrasound is enabling providers to deliver tailored, evidence-based protocols that shorten downtime and broaden candidacy.

Provider models are also shifting: traditional dermatology clinics now operate alongside franchised chains, medical spas, and hybrid barbershop-adjacent grooming clinics, creating new access points and competitive dynamics. Treatment frequency and outcome duration are increasingly central to consumer decision-making, with maintenance/booster models and series-based regimens becoming commonplace, and outcome expectations ranging from temporary to semi-permanent, long-lasting, or permanent results. Collectively, these shifts compel manufacturers and providers to prioritize device versatility, training ecosystems, and patient retention strategies.

As market players navigate these transitions, success will depend on integrating multidisciplinary clinical expertise, investing in evidence generation, and redesigning commercial models to serve both episodic and ongoing care needs effectively.

Trade policy shifts are reshaping sourcing, pricing, and operational resilience for devices, consumables, and clinic economics across the value chain

The cumulative impact of trade policy developments announced in and around 2025 is creating a more complex operating environment for manufacturers, distributors, and clinics reliant on cross-border supply chains. Tariff adjustments have increased the cost pressure on capital equipment, consumables, and specialized components used in devices and at-home technologies. As a result, procurement teams are reevaluating sourcing strategies and inventory policies to mitigate lead-time variability and margin erosion. In tandem, some manufacturers are accelerating regional manufacturing or assembly to reduce exposure to import duties and to respond more quickly to local regulatory or reimbursement changes.

On the demand side, higher landed costs are prompting selective price adjustments and a sharper emphasis on value communication to patients. Clinics are responding by refining service bundles, emphasizing outcome duration, and promoting treatment packages with maintenance or series-based architectures to preserve revenue predictability. Meanwhile, manufacturers are negotiating revised distribution agreements and exploring creative financing models, including equipment-as-a-service, to lower adoption barriers for providers.

Regulatory and customs compliance has also become more salient, with firms investing in enhanced documentation, classification accuracy, and trade counsel to avoid disruption. Ultimately, the cumulative effect of tariff shifts is to accelerate localization, deepen partnerships across the value chain, and intensify the focus on cost-to-serve optimization while maintaining clinical standards.

A multi-dimensional segmentation framework linking treatment modality, enabling technology, provider models, and outcome duration to reveal strategic growth levers

Segmentation analysis reveals differentiated demand drivers and operational priorities that vary by treatment type, technology, provider model, treatment frequency, and outcome horizon. Based on Treatment Type the competitive landscape includes Minimally Invasive Procedures alongside Non-Invasive Procedures, Surgical Procedures, and Topicals & At-Home formats; the Minimally Invasive Procedures category further encompasses Fat Transfer, Laser-Assisted Lipolysis, Liposuction, and Thread Lifts, while Non-Invasive Procedures extend through Body Contouring, Botox Injectables, Hair Removal, Hair Restoration (Non-Surgical), Pigment/Scar Correction, Skin Resurfacing, and Skin Tightening, and Surgical Procedures cover Body Surgery, Facial Surgery, and Hair Transplant, with Topicals & At-Home comprising At-Home Devices and Skincare. Based on Technology market activity centers around Laser Technology, Radiofrequency, and Ultrasound, each with distinct development cycles and clinical evidence requirements. Based on Provider Type the ecosystem spans Barbershop-Adjacent Grooming Clinics, Dermatology Clinics, Franchised Chains, and Medical Spas, which influence referral flows, pricing power, and brand building. Based on Treatment Frequency patient pathways range from Maintenance/Booster and One-Time interventions to Series-Based protocols, shaping lifetime value models. Based on Outcome Duration outcomes are framed as Long-Lasting (>24 Months), Permanent, Semi-Permanent (6-24 Months), or Temporary (<=6 Months), driving expectation management and post-procedure communication.

These segmentation axes interact in predictable ways: technologies that deliver longer outcome duration are more likely to be adopted in surgical and minimally invasive settings, while non-invasive approaches and at-home devices align with serial maintenance strategies. Provider types that emphasize convenience and volume favor quick-turn modalities and packaged plans, whereas specialty dermatology clinics prioritize evidence and bespoke protocols for premium pricing. Understanding these intersections enables product roadmaps and go-to-market approaches to be precisely targeted to clinical workflows and patient preferences.

Divergent regional adoption patterns and regulatory nuances creating tailored opportunities across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics are shaping distinct competitive and demand landscapes that have direct implications for commercialization strategies. In the Americas, consumer acceptance of male aesthetics is high and provider density is strong, which creates opportunities for differentiated clinic formats and subscription-oriented maintenance models. The regulatory environment and payer interplay in parts of the region encourage clinics to emphasize clinical validation and patient safety while adopting flexible pricing constructs and financing options to broaden accessibility.

Europe, Middle East & Africa present a heterogeneous mix of markets where cultural attitudes toward aesthetics, reimbursement frameworks, and provider credentialing vary significantly. Western European markets often prioritize clinical evidence and specialist-led care, while several markets in the Middle East show strong demand for surgical and premium aesthetic services driven by discretionary spending. Africa's markets are nascent but increasingly receptive to non-invasive and at-home offerings where access to specialist clinics is limited.

Asia-Pacific remains highly dynamic, with rapid uptake of minimally invasive and non-invasive technologies driven by urbanization, mobile-first consumer engagement, and strong demand for hair restoration and skin rejuvenation services. Regional manufacturing hubs and an active device ecosystem also make Asia-Pacific a focal point for innovation and cost-competitive production. These regional contrasts necessitate tailored channel strategies, regulatory navigation, and culturally informed marketing to achieve sustained adoption.

Companies that integrate device innovation with clinician training, digital enablement, and services-based revenue models outpace competitors in adoption and retention

Competitive behavior among leading players is now defined by integrated go-to-market strategies that combine product innovation, training ecosystems, and service enablement. Companies that invest in clinician education and certification programs strengthen device adoption and reduce variability in outcomes, which in turn supports premium positioning and repeat business. Similarly, firms that build modular platforms capable of supporting multiple technologies and treatment indications enhance customer lifetime value and reduce churn among clinic partners.

Strategic partnerships and ecosystem plays are increasingly common; manufacturers are collaborating with software vendors, financing partners, and clinical networks to deliver a full-stack solution that addresses procurement, training, patient acquisition, and outcome tracking. Mergers and acquisitions remain a lever for scale, enabling firms to secure distribution reach, complementary technologies, or in-clinic brands that accelerate market penetration. At the same time, nimble challengers that focus on specific subsegments-such as at-home devices or niche surgical tools-are pushing incumbents to prioritize speed-to-clinic and targeted evidence generation.

Ultimately, winning companies balance clinical rigor, commercial flexibility, and a services-oriented mindset, while deploying data to demonstrate outcomes, justify pricing, and refine segmentation strategies across provider types and regional markets.

Practical strategic moves to stabilize supply chains, monetize outcomes, and expand provider reach while preserving clinical integrity and patient lifetime value

Leaders should prioritize a set of actionable moves that address both near-term resilience and medium-term growth. First, de-risk supply chains by diversifying suppliers, qualifying secondary manufacturers, and evaluating regional assembly options to mitigate tariff-driven cost volatility and delivery delays. Second, shift commercial conversations from price to demonstrable outcomes by investing in high-quality clinical evidence, real-world outcome tracking, and patient-reported metrics that support premium positioning and subscription offerings.

Third, create differentiated provider value propositions through training academies, standardized protocols, and flexible financing models such as equipment-as-a-service that lower adoption barriers for smaller clinics. Fourth, expand access through hybrid distribution strategies that combine specialist partnerships with non-traditional channels such as grooming clinics and franchised chains, while ensuring appropriate credentialing and quality controls. Fifth, design consumer engagement strategies that reflect the treatment frequency and outcome duration most relevant to target segments-one-time procedural buyers will require different messaging than maintenance/booster audiences who value predictable, recurring care.

Finally, embed regulatory and trade scenario planning into strategic decision-making to prepare for policy shifts, and invest in digital patient journeys that streamline education, booking, and post-procedure follow-up to lock in lifetime value. Executing these priorities will enhance resilience and create the foundation for scalable, sustainable growth.

A rigorous mixed-methods approach combining primary stakeholder engagement, secondary evidence synthesis, and iterative validation to ensure robust, decision-ready insights

The research methodology combines primary qualitative and quantitative engagement with domain experts, triangulated with authoritative secondary sources and systematic data validation processes. Primary research included structured interviews with a representative cross-section of stakeholders across clinical practice, device manufacturing, distribution, and retail-facing providers to capture first-hand perspectives on technology adoption, reimbursement interplay, patient preferences, and operational challenges. Supplementary surveys with clinicians and clinic operators quantified treatment frequency patterns, typical patient journeys, and common barriers to adoption.

Secondary research entailed a methodical review of peer-reviewed clinical publications, regulatory guidance, patent filings, company disclosures, and conference proceedings to verify technological claims and evidence bases. Data triangulation ensured that trends observed in primary research aligned with documented clinical outcomes and public disclosures. The analysis also employed scenario modeling to stress-test supply chain and policy impacts, and internal validation workshops were conducted with external clinical advisors to ensure interpretive accuracy and practical relevance.

Throughout the process, quality controls included source attribution, conflict-of-interest assessments, and iterative refinement of assumptions based on emergent primary insights. This layered approach ensures that conclusions are robust, actionable, and relevant to decision-makers operating in a rapidly evolving male aesthetics environment.

Sustained success depends on aligning clinical evidence, resilient operations, and consumer-centric commercialization to navigate policy and regional complexity

The male aesthetics landscape is maturing into a multi-faceted market where clinical innovation, consumer behavior, and commercial ingenuity intersect. Providers and manufacturers that successfully align product capabilities with demonstrable outcomes and scalable provider enablement will capture disproportionate value. The interplay of treatment modality, enabling technology, and provider type creates natural segmentation opportunities that can be monetized through tailored pricing, financing, and patient engagement strategies.

Trade policy developments and regional differences add layers of complexity, but they also create incentives for localization, strategic partnerships, and new service models that reduce cost-to-serve and accelerate time-to-market. Companies that emphasize clinician education, invest in longitudinal outcome tracking, and incorporate flexible commercial structures will be best positioned to manage near-term headwinds while unlocking long-term growth. In sum, thoughtful alignment of clinical evidence, operational resilience, and customer-centric commercialization will determine which organizations lead the next phase of market expansion.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Male Aesthetics Market, by Treatment Type

  • 8.1. Minimally Invasive Procedures
    • 8.1.1. Fat Transfer
    • 8.1.2. Laser-Assisted Lipolysis
    • 8.1.3. Liposuction
    • 8.1.4. Thread Lifts
  • 8.2. Non-Invasive Procedures
    • 8.2.1. Body Contouring
    • 8.2.2. Botox Injectables
    • 8.2.3. Hair Removal
    • 8.2.4. Hair Restoration (Non-Surgical)
    • 8.2.5. Pigment/Scar Correction
    • 8.2.6. Skin Resurfacing
    • 8.2.7. Skin Tightening
  • 8.3. Surgical Procedures
    • 8.3.1. Body Surgery
    • 8.3.2. Facial Surgery
    • 8.3.3. Hair Transplant
  • 8.4. Topicals & At-Home
    • 8.4.1. At-Home Devices
    • 8.4.2. Skincare

9. Male Aesthetics Market, by Technology

  • 9.1. Laser Technology
  • 9.2. Radiofrequency
  • 9.3. Ultrasound

10. Male Aesthetics Market, by Provider Type

  • 10.1. Barbershop-Adjacent Grooming Clinics
  • 10.2. Dermatology Clinics
  • 10.3. Franchised Chains
  • 10.4. Medical Spas

11. Male Aesthetics Market, by Treatment Frequency

  • 11.1. Maintenance/Booster
  • 11.2. One-Time
  • 11.3. Series-Based

12. Male Aesthetics Market, by Outcome Duration

  • 12.1. Long-Lasting (>24 Months)
  • 12.2. Permanent
  • 12.3. Semi-Permanent (6-24 Months)
  • 12.4. Temporary (<=6 Months)

13. Male Aesthetics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Male Aesthetics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Male Aesthetics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Male Aesthetics Market

17. China Male Aesthetics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbvie Inc.
  • 18.6. Acumed, LLC by Colson Medical, LLC
  • 18.7. Alma Lasers, Ltd.
  • 18.8. Anthony Skin LLC
  • 18.9. Candela Corporation
  • 18.10. Cartessa Aesthetics
  • 18.11. Cutera, Inc.
  • 18.12. Cynosure, LLC
  • 18.13. Galderma SA
  • 18.14. Hanson Medical, Inc.
  • 18.15. Implantech Associates Inc.
  • 18.16. Inmode Ltd
  • 18.17. Institut Straumann AG
  • 18.18. Integra LifeSciences Corporation
  • 18.19. Ipsen Pharma
  • 18.20. Jeisys Medical Inc.
  • 18.21. Johnson & Johnson Services Inc.
  • 18.22. KLS Martin Group
  • 18.23. Lattice Medical SAS
  • 18.24. Medytox, Inc.
  • 18.25. Merz Aesthetics, Inc.
  • 18.26. Nobel Biocare Services AG
  • 18.27. Quanta System S.p.A.
  • 18.28. Solta Medical by Bausch Health Companies Inc.
  • 18.29. Stryker Corporation
  • 18.30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MALE AESTHETICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MALE AESTHETICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MALE AESTHETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MALE AESTHETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MALE AESTHETICS MARKET SIZE, BY FAT TRANSFER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MALE AESTHETICS MARKET SIZE, BY FAT TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MALE AESTHETICS MARKET SIZE, BY FAT TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER-ASSISTED LIPOLYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER-ASSISTED LIPOLYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER-ASSISTED LIPOLYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MALE AESTHETICS MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MALE AESTHETICS MARKET SIZE, BY LIPOSUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MALE AESTHETICS MARKET SIZE, BY LIPOSUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MALE AESTHETICS MARKET SIZE, BY THREAD LIFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MALE AESTHETICS MARKET SIZE, BY THREAD LIFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MALE AESTHETICS MARKET SIZE, BY THREAD LIFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY CONTOURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY CONTOURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY CONTOURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MALE AESTHETICS MARKET SIZE, BY BOTOX INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MALE AESTHETICS MARKET SIZE, BY BOTOX INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MALE AESTHETICS MARKET SIZE, BY BOTOX INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR RESTORATION (NON-SURGICAL), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR RESTORATION (NON-SURGICAL), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR RESTORATION (NON-SURGICAL), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MALE AESTHETICS MARKET SIZE, BY PIGMENT/SCAR CORRECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MALE AESTHETICS MARKET SIZE, BY PIGMENT/SCAR CORRECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MALE AESTHETICS MARKET SIZE, BY PIGMENT/SCAR CORRECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN RESURFACING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN RESURFACING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN RESURFACING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN TIGHTENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN TIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKIN TIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MALE AESTHETICS MARKET SIZE, BY BODY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MALE AESTHETICS MARKET SIZE, BY FACIAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MALE AESTHETICS MARKET SIZE, BY FACIAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MALE AESTHETICS MARKET SIZE, BY FACIAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MALE AESTHETICS MARKET SIZE, BY HAIR TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MALE AESTHETICS MARKET SIZE, BY AT-HOME DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MALE AESTHETICS MARKET SIZE, BY AT-HOME DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MALE AESTHETICS MARKET SIZE, BY AT-HOME DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKINCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKINCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MALE AESTHETICS MARKET SIZE, BY SKINCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MALE AESTHETICS MARKET SIZE, BY LASER TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MALE AESTHETICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MALE AESTHETICS MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MALE AESTHETICS MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MALE AESTHETICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MALE AESTHETICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MALE AESTHETICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MALE AESTHETICS MARKET SIZE, BY BARBERSHOP-ADJACENT GROOMING CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MALE AESTHETICS MARKET SIZE, BY BARBERSHOP-ADJACENT GROOMING CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MALE AESTHETICS MARKET SIZE, BY BARBERSHOP-ADJACENT GROOMING CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MALE AESTHETICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MALE AESTHETICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MALE AESTHETICS MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MALE AESTHETICS MARKET SIZE, BY FRANCHISED CHAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MALE AESTHETICS MARKET SIZE, BY FRANCHISED CHAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MALE AESTHETICS MARKET SIZE, BY FRANCHISED CHAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MALE AESTHETICS MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MALE AESTHETICS MARKET SIZE, BY MEDICAL SPAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MALE AESTHETICS MARKET SIZE, BY MEDICAL SPAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MALE AESTHETICS MARKET SIZE, BY MAINTENANCE/BOOSTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MALE AESTHETICS MARKET SIZE, BY MAINTENANCE/BOOSTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MALE AESTHETICS MARKET SIZE, BY MAINTENANCE/BOOSTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MALE AESTHETICS MARKET SIZE, BY ONE-TIME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MALE AESTHETICS MARKET SIZE, BY ONE-TIME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MALE AESTHETICS MARKET SIZE, BY ONE-TIME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MALE AESTHETICS MARKET SIZE, BY SERIES-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MALE AESTHETICS MARKET SIZE, BY SERIES-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MALE AESTHETICS MARKET SIZE, BY SERIES-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MALE AESTHETICS MARKET SIZE, BY LONG-LASTING (>24 MONTHS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MALE AESTHETICS MARKET SIZE, BY LONG-LASTING (>24 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MALE AESTHETICS MARKET SIZE, BY LONG-LASTING (>24 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MALE AESTHETICS MARKET SIZE, BY PERMANENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MALE AESTHETICS MARKET SIZE, BY PERMANENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MALE AESTHETICS MARKET SIZE, BY PERMANENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MALE AESTHETICS MARKET SIZE, BY SEMI-PERMANENT (6-24 MONTHS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MALE AESTHETICS MARKET SIZE, BY SEMI-PERMANENT (6-24 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MALE AESTHETICS MARKET SIZE, BY SEMI-PERMANENT (6-24 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MALE AESTHETICS MARKET SIZE, BY TEMPORARY (<=6 MONTHS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MALE AESTHETICS MARKET SIZE, BY TEMPORARY (<=6 MONTHS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MALE AESTHETICS MARKET SIZE, BY TEMPORARY (<=6 MONTHS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MALE AESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS MALE AESTHETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MALE AESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 208. GCC MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 209. GCC MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 210. GCC MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 211. GCC MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. GCC MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. G7 MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 240. G7 MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 241. G7 MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. G7 MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 250. NATO MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 251. NATO MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL MALE AESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA MALE AESTHETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA MALE AESTHETICS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA MALE AESTHETICS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA MALE AESTHETICS MARKET SIZE, BY NON-INVASIVE PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA MALE AESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA MALE AESTHETICS MARKET SIZE, BY TOPICALS & AT-HOME, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA MALE AESTHETICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA MALE AESTHETICS MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA MALE AESTHETICS MARKET SIZE, BY TREATMENT FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA MALE AESTHETICS MARKET SIZE, BY OUTCOME DURATION, 2018-2032 (USD MILLION)